| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_961e5534d0dface3eddaa178ddd9b17d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_426993a71eaf37478149f6b5e13a3e56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69efe104ae722a804c5206d406889444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f7669709de72eeb8663905b4eec82657 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4184
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
| filingDate |
2012-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_224da1e68811e72694c158e339ae9b52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c5f6e4f121767dfb016a2ebe664c2de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d1e419a56b1033a4bb82a79f96e115d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5431a0fd05d27ca9c6e452d747474542 |
| publicationDate |
2013-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013046003-A1 |
| titleOfInvention |
Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine for treating retinal diseases |
| abstract |
The present invention relates to a method for treating retinal diseases and a method for retinal neuroprotection, in a patient in need thereof which comprises of administering a therapeutically effective amount of a pharmaceutical composition comprising a therapeutically effective amount of 4-bromo-N-(imidazolidin-2-ylidene)-1H-benzimidazol-5-amine or pharmaceutically acceptable salts thereof. |
| priorityDate |
2011-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |